Search research articles
Contact Us
Filters
Showing results (221-230 of 315) with videos related to
Page
of 32
Sort By:
The Journal of Biological Chemistry
|
August 25, 2004
Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis
Gareth J Griffiths, Mei Yee Koh, Valerie G Brunton, et al.
Plos One
|
August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma
Nada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.
ACS Chemical Biology
|
September 22, 2011
Targeting the Hsp90 molecular chaperone with novel macrolactams. Synthesis, structural, binding, and cellular studies
James E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Journal of Medicinal Chemistry
|
June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design
Brian W Dymock, Xavier Barril, Paul A Brough, et al.
Bioorganic & Medicinal Chemistry
|
October 20, 2006
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors
Masahiko Hayakawa, Hiroyuki Kaizawa, Ken-Ichi Kawaguchi, et al.
Assay and Drug Development Technologies
|
July 20, 2007
Application of meso scale technology for the measurement of phosphoproteins in human tumor xenografts
Sharon M Gowan, Anthea Hardcastle, Albert E Hallsworth, et al.
Journal of Medicinal Chemistry
|
April 28, 2016
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70
Matthew D Cheeseman, Isaac M Westwood, Olivier Barbeau, et al.
Molecular Cell
|
October 17, 2008
Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37
Cara K Vaughan, Mehdi Mollapour, Jennifer R Smith, et al.
Cancer Research
|
January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
Nada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
Molecular Cancer Therapeutics
|
October 18, 2005
Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Lindsay Stimson, Martin G Rowlands, Yvette M Newbatt, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 315) with videos related to
Sort By:
Page
of 32
The Journal of Biological Chemistry
|
August 25, 2004
Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis
Gareth J Griffiths, Mei Yee Koh, Valerie G Brunton, et al.
Plos One
|
August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma
Nada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.
ACS Chemical Biology
|
September 22, 2011
Targeting the Hsp90 molecular chaperone with novel macrolactams. Synthesis, structural, binding, and cellular studies
James E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Journal of Medicinal Chemistry
|
June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design
Brian W Dymock, Xavier Barril, Paul A Brough, et al.
Bioorganic & Medicinal Chemistry
|
October 20, 2006
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors
Masahiko Hayakawa, Hiroyuki Kaizawa, Ken-Ichi Kawaguchi, et al.
Assay and Drug Development Technologies
|
July 20, 2007
Application of meso scale technology for the measurement of phosphoproteins in human tumor xenografts
Sharon M Gowan, Anthea Hardcastle, Albert E Hallsworth, et al.
Journal of Medicinal Chemistry
|
April 28, 2016
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70
Matthew D Cheeseman, Isaac M Westwood, Olivier Barbeau, et al.
Molecular Cell
|
October 17, 2008
Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37
Cara K Vaughan, Mehdi Mollapour, Jennifer R Smith, et al.
Cancer Research
|
January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
Nada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
Molecular Cancer Therapeutics
|
October 18, 2005
Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Lindsay Stimson, Martin G Rowlands, Yvette M Newbatt, et al.
Page
of 32